Adherence to HAART therapy measured by electronic monitoring in newly diagnosed HIV patients in Botswana - Test2 - elhamkhani - TriplyDB

Adherence to HAART therapy measured by electronic monitoring in newly diagnosed HIV patients in Botswana

Adherence to HAART therapy measured by electronic monitoring in newly diagnosed HIV patients in Botswana

http://www.wikidata.org/entity/Q28221847

about

Measuring adherence to antiretroviral treatment in resource-poor settings: the feasibility of collecting routine data for key indicators.Patient retention and adherence to antiretrovirals in a large antiretroviral therapy program in Nigeria: a longitudinal analysis for risk factors Knowledge and adherence to antiretroviral therapy among adult people living with HIV/AIDS treated in the health care centers of the association "Espoir Vie Togo" in Togo, West Africa.The impact of neuropsychological functioning on adherence to HAART in HIV-infected substance abuse patients Screening for hazardous alcohol use and depressive symptomatology among HIV-infected patients in Nigeria: prevalence, predictors, and association with adherence.HIV-infected individuals with co-occurring bipolar disorder evidence poor antiretroviral and psychiatric medication adherence.A proposal for quality standards for measuring medication adherence in research Memory-based strategies for antiretroviral medication management: an evaluation of clinical predictors, adherence behavior awareness, and effectiveness.Exploring ART intake scenes in a human rights-based intervention to improve adherence: a randomized controlled trial Binge drinking is associated with differences in weekday and weekend adherence in HIV-infected individuals.A scoping review of studies comparing the medication event monitoring system (MEMS) with alternative methods for measuring medication adherence.Mobile phone technologies improve adherence to antiretroviral treatment in a resource-limited setting: a randomized controlled trial of text message reminders Effect of herpes simplex suppression on incidence of HIV among women in Tanzania.Use of novel technology-based techniques to improve alcohol-related outcomes in clinical trials.Approaches to identifying appropriate medication adherence assessments for HIV infected individuals with comorbid bipolar disorder.Barriers to antiretroviral adherence in HIV-positive patients receiving free medication in Kayunga, Uganda.Correlation of Adherence by Pill Count, Self-report, MEMS and Plasma Drug Levels to Treatment Response Among Women Receiving ARV Therapy for PMTCT in Kenya.Monitoring adherence rates in glaucoma patients using the Travatan Dosing Aid. A 6-month study comparing patients on travoprost 0.004% and patients on travoprost 0.004%/timolol 0.5% fixed combination.Adherence to highly active antiretroviral therapy (HAART): a meta-analysis.Pilot evaluation of a second-generation electronic pill box for adherence to Bedaquiline and antiretroviral therapy in drug-resistant TB/HIV co-infected patients in KwaZulu-Natal, South Africa.

P2860

Q33532759-F35155D3-6C5C-4F8F-A666-CFD356F418FC Q33582279-E23263B8-7C2A-4869-8752-F317A5B6C544 Q33694858-1E786784-7C18-4F9B-8CFE-EEBDE3A6ACC7 Q33797580-E52CFD90-036B-4E9F-8384-C05AF70438A5 Q34181703-614EC332-7572-423E-9340-D30BC21830AA Q35957349-34399A93-C60F-4DD4-BA5D-D51DB37EDCAB Q36210156-C1FBD6FC-A046-4916-B770-26079E61E93C Q36511759-B104409A-3E86-4D6B-931F-410EB60FE29A Q36542552-4D52A141-CE9B-4664-BE36-5C66659711A8 Q36882901-588096EE-D4C4-4C5A-B884-70E8FB82FDE2 Q37030734-40D22DE4-ED53-40F3-BAF5-540C77913E45 Q37032515-2E99C142-2F18-42EE-BF7E-E33240D830F2 Q37098217-B1BC942C-0CC2-4C13-B3E2-6EE87B3D1182 Q37276159-A27AC768-7BB2-4B41-8FE4-576B2BEA02C9 Q37651830-E63FDD36-B1D4-4493-A7E7-AAE5C33E36FE Q38869321-1CBD6BED-4EC2-4622-A19F-E4E36B3D155C Q40335852-081DF3A6-0D2D-42B6-90A5-506328CC6AE2 Q42649418-51137E7A-5836-4804-B497-741A4B4068BC Q45889695-FE1E5327-850E-421C-87B2-57958616A798 Q52324625-55A5FA3C-455A-40BC-A9F3-B9B6CCF1019B

P2860

Adherence to HAART therapy measured by electronic monitoring in newly diagnosed HIV patients in Botswana

http://www.wikidata.org/entity/Q28221847

description

2007 nî lūn-bûn

@nan

2007 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Adherence to HAART therapy mea ...... nosed HIV patients in Botswana

@ast

Adherence to HAART therapy mea ...... nosed HIV patients in Botswana

@en

Adherence to HAART therapy mea ...... nosed HIV patients in Botswana

@nl

type

label

Adherence to HAART therapy mea ...... nosed HIV patients in Botswana

@ast

Adherence to HAART therapy mea ...... nosed HIV patients in Botswana

@en

Adherence to HAART therapy mea ...... nosed HIV patients in Botswana

@nl

prefLabel

Adherence to HAART therapy mea ...... nosed HIV patients in Botswana

@ast

Adherence to HAART therapy mea ...... nosed HIV patients in Botswana

@en

Adherence to HAART therapy mea ...... nosed HIV patients in Botswana

@nl

P1433

Q28221847-56393C19-945C-49DA-9977-67DA42DE9184

P1476

Q28221847-AA480DEC-7D6D-4183-AFD6-90C7BAE76F34

P2093

Q28221847-243C98E1-825B-4E09-9524-91C4A3558F32

Q28221847-4C2EDB94-8B60-4F6D-8CC0-8CE4226096A0

Q28221847-6A74F66F-7837-49D6-BE24-11EE65F7A9E0

Q28221847-95D1A56A-424F-4714-AB45-D7B1E86ABBBC

Q28221847-AE2F62CA-5417-492E-BB94-ACC2223F56AA

Q28221847-C8F1E0BD-4541-4DF5-B178-44BA0F6257DA

Q28221847-CB21B5EC-034B-4D2B-897F-4593EDD0E43F

P2860

Q28221847-186764B8-EA0A-423E-B27D-C55BA820692F

Q28221847-2179D0CB-DB25-4311-A5FB-CA4AA1BD1027

Q28221847-3D9FE984-8012-452B-B355-BBFFBE171312

Q28221847-4DC8FC52-9646-4C3B-87F3-26F9F007CF3C

Q28221847-585AE416-EE64-49A6-81CB-FEDFC1C8AE35

Q28221847-5E722DF5-2BD6-4572-8023-6DC7434788C0

Q28221847-7790EE36-DABF-4D5A-A08E-BE4131BB11CC

Q28221847-8B0D1B78-1EB6-4A21-8FE6-2B7C6238C2E6

Q28221847-B3688914-7C3C-44C4-BFF0-2A6307D7832D

Q28221847-B4783A8A-A101-44C7-864B-C8C0D3FA0981

P2888

Q28221847-80C1CFF4-6852-4831-9958-58AFFDAB0A64

P304

Q28221847-01DB6605-F1A8-4CFB-8AE4-CC30DA307974

P31

Q28221847-7F48AC72-CB55-4539-9DF8-B64DE31E719D

P356

Q28221847-02F9B397-ECBD-451F-842E-891055DFCCFE

P407

Q28221847-BF83F21F-7FAF-47A9-B45F-277F5FA624D8

P433

Q28221847-427DD704-136C-4311-B4A4-8376A188ACC7

P478

Q28221847-5FE3E17F-1C05-46BD-A02E-CB18908B1B35

P50

Q28221847-9E896F33-7F5D-4786-AC10-9147E72D9BA8

P577

Q28221847-2B966567-A3B4-436B-B9A2-AF2790849FE6

P5875

Q28221847-ABE111B8-EBDD-4CBD-92E2-1D6FB9CA93C4

P6179

Q28221847-A349ED19-C9DC-4E63-BF6A-550F9E64B474

P698

Q28221847-3D949A82-6D6B-49C0-A11F-2E03F7CAD1F9

P921

Q28221847-0F420ECC-D656-4DCD-A19B-D7043A3F2804

P932

Q28221847-86EAB002-9B4B-40AA-B3DE-B71D4C4B089F

P356

S00228-007-0369-2

P1433

European Journal of Clinical Pharmacology

P1476

Adherence to HAART therapy mea ...... nosed HIV patients in Botswana

@en

P2093

Adam Cohen

http://www.w3.org/2001/XMLSchema#string

Bene Anand

http://www.w3.org/2001/XMLSchema#string

Henry Uchechukwaka Iwebor

http://www.w3.org/2001/XMLSchema#string

Jacobus Stiekema

http://www.w3.org/2001/XMLSchema#string

Pande Rakesh

http://www.w3.org/2001/XMLSchema#string

Paulus Kristanto

http://www.w3.org/2001/XMLSchema#string

Reinout Vriesendorp

http://www.w3.org/2001/XMLSchema#string

P2860

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

Successful projection of the time course of drug concentration in plasma during a 1-year period from electronically compiled dosing-time data used as input to individually parameterized pharmacokinetic models.

Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice.

Development of drug resistance in patients receiving combinations of zidovudine, didanosine and nevirapine.

Adherence in chronic disease.

Antiretroviral medication compliance in patients with AIDS.

A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: the INCAS Trial. Italy, The Netherlands, Canada and Australia Study.

Gonorrhea incidence and HIV testing and counseling among adolescents and young adults seen at a clinic for sexually transmitted diseases.

Adherence to protease inhibitor therapy and outcomes in patients with HIV infection

Barriers to antiretroviral adherence for patients living with HIV infection and AIDS in Botswana.

P2888

s00228-007-0369-2

P304

1115-21

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00228-007-0369-2

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

63

http://www.w3.org/2001/XMLSchema#string

P50

Bernard Vrijens

P577

2007-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5961493

http://www.w3.org/2001/XMLSchema#string

P6179

1044135538

http://www.w3.org/2001/XMLSchema#string

P698

17882408

http://www.w3.org/2001/XMLSchema#string

P921

P932

2071959

http://www.w3.org/2001/XMLSchema#string